Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Incorporated(INSM) | 1,550,000 | 1,600,000 | +50,000 | $118.25M | $161.02M | 15.04% | +$42.77M |
| Boston Scientific Corporation(BSX) | 650,000 | 550,000 | -100,000 | $65.57M | $59.08M | 5.52% | -$6.50M |
| Tenet Healthcare Corporation(THC) | 275,000 | 275,000 | 0 | $36.99M | $48.40M | 4.52% | +$11.41M |
| Encompass Health Corporation(EHC) | 270,000 | 320,000 | +50,000 | $27.35M | $39.24M | 3.67% | +$11.90M |
| Mineralys Therapeutics, Inc.(MLYS) | 2,300,000 | 2,700,000 | +400,000 | $36.52M | $36.53M | 3.41% | +$7.0K |
| Cytokinetics, Incorporated(CYTK) | 1,100,000 | 1,000,000 | -100,000 | $44.21M | $33.04M | 3.09% | -$11.17M |
| BrightSpring Health Services, Inc.(BTSG) | 775,000 | 1,250,000 | +475,000 | $14.02M | $29.49M | 2.75% | +$15.47M |
| Vera Therapeutics, Inc.CL A(VERA) | 1,150,000 | 1,150,000 | 0 | $27.62M | $27.09M | 2.53% | -$529.0K |
| Quest Diagnostics Incorporated(DGX) | 0 | 150,000 | +150,000 | $0 | $26.94M | 2.52% | +$26.94M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 50,000 | +50,000 | $0 | $26.25M | 2.45% | +$26.25M |
| Novartis AGADR(NVS) | 250,000 | 200,000 | -50,000 | $27.87M | $24.20M | 2.26% | -$3.67M |
| Cardinal Health, Inc.(CAH) | 0 | 140,000 | +140,000 | $0 | $23.52M | 2.20% | +$23.52M |
| Elevance Health, Inc.(ELV) | 65,000 | 60,000 | -5,000 | $28.27M | $23.34M | 2.18% | -$4.93M |
| RadNet, Inc.(RDNT) | 250,000 | 400,000 | +150,000 | $12.43M | $22.76M | 2.13% | +$10.33M |
| Fresenius Medical Care AGADR(FMS) | 680,000 | 750,000 | +70,000 | $16.93M | $21.43M | 2.00% | +$4.50M |
| Eli Lilly and Company(LLY) | 0 | 25,000 | +25,000 | $0 | $19.49M | 1.82% | +$19.49M |
| Neurocrine Biosciences, Inc.(NBIX) | 150,000 | 150,000 | 0 | $16.59M | $18.85M | 1.76% | +$2.26M |
| uniQure N.V.SHS(QURE) | 1,250,000 | 1,350,000 | +100,000 | $13.25M | $18.82M | 1.76% | +$5.57M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 50,000 | 55,000 | +5,000 | $13.50M | $17.93M | 1.68% | +$4.43M |
| DexCom, Inc.(DXCM) | 100,000 | 200,000 | +100,000 | $6.83M | $17.46M | 1.63% | +$10.63M |
| Charles River Laboratories International, Inc.(CRL) | 0 | 115,000 | +115,000 | $0 | $17.45M | 1.63% | +$17.45M |
| Medtronic plcSHS(MDT) | 300,000 | 200,000 | -100,000 | $26.96M | $17.43M | 1.63% | -$9.52M |
| CVS Health Corporation(CVS) | 200,000 | 250,000 | +50,000 | $13.55M | $17.25M | 1.61% | +$3.69M |
| Pfizer Inc.(PFE) | 300,000 | 700,000 | +400,000 | $7.60M | $16.97M | 1.59% | +$9.37M |
| Edwards Lifesciences Corp | 125,000 | 200,000 | +75,000 | $9.06M | $15.64M | 1.46% | +$6.58M |
| GE HealthCare Technologies Inc.(GEHC) | 150,000 | 200,000 | +50,000 | $12.11M | $14.81M | 1.38% | +$2.71M |
| AstraZeneca PLCADR(AZN) | 0 | 200,000 | +200,000 | $0 | $13.98M | 1.31% | +$13.98M |
| Edgewise Therapeutics, Inc.(EWTX) | 675,000 | 1,000,000 | +325,000 | $14.85M | $13.11M | 1.22% | -$1.74M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 1,250,000 | +1,250,000 | $0 | $12.69M | 1.19% | +$12.69M |
| Revolution Medicines, Inc.(RVMD) | 250,000 | 325,000 | +75,000 | $8.84M | $11.96M | 1.12% | +$3.12M |
| 89bio Inc | 1,050,000 | 1,050,000 | 0 | $7.63M | $10.31M | 0.96% | +$2.68M |
| Penumbra, Inc.(PEN) | 35,000 | 40,000 | +5,000 | $9.36M | $10.27M | 0.96% | +$905.9K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 200,000 | 200,000 | 0 | $7.81M | $9.44M | 0.88% | +$1.63M |
| Inspire Medical Systems, Inc.(INSP) | 65,000 | 70,000 | +5,000 | $10.35M | $9.08M | 0.85% | -$1.27M |
| Acadia Healthcare Company, Inc.(ACHC) | 250,000 | 400,000 | +150,000 | $7.58M | $9.08M | 0.85% | +$1.50M |
| Beam Therapeutics Inc.(BEAM) | 0 | 500,000 | +500,000 | $0 | $8.51M | 0.79% | +$8.51M |
| Hologic Inc | 0 | 125,000 | +125,000 | $0 | $8.14M | 0.76% | +$8.14M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 200,000 | 200,000 | 0 | $10.27M | $8.10M | 0.76% | -$2.17M |
| Rezolute, Inc.(RZLT) | 500,000 | 1,800,000 | +1,300,000 | $1.45M | $8.03M | 0.75% | +$6.58M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 120,000 | +120,000 | $0 | $7.58M | 0.71% | +$7.58M |
| Baxter Intl Inc | 500,000 | 250,000 | -250,000 | $17.11M | $7.57M | 0.71% | -$9.54M |
| AbbVie Inc.(ABBV) | 60,000 | 40,000 | -20,000 | $12.57M | $7.42M | 0.69% | -$5.15M |
| McKesson Corporation(MCK) | 12,000 | 10,000 | -2,000 | $8.08M | $7.33M | 0.68% | -$748.1K |
| Roivant Sciences Ltd.SHS(ROIV) | 600,000 | 600,000 | 0 | $6.05M | $6.76M | 0.63% | +$708.0K |
| iRhythm Holdings, Inc.(IRTC) | 0 | 40,000 | +40,000 | $0 | $6.16M | 0.58% | +$6.16M |
| Agilent Technologies, Inc.(A) | 0 | 50,000 | +50,000 | $0 | $5.90M | 0.55% | +$5.90M |
| REGENXBIO Inc.(RGNX) | 925,000 | 700,000 | -225,000 | $6.61M | $5.75M | 0.54% | -$866.8K |
| Verona Pharma PlcADS | 115,000 | 60,000 | -55,000 | $7.30M | $5.67M | 0.53% | -$1.63M |
| Alignment Healthcare, Inc.(ALHC) | 200,000 | 400,000 | +200,000 | $3.72M | $5.60M | 0.52% | +$1.88M |
| Atyr Pharma Inc | 700,000 | 1,050,000 | +350,000 | $2.11M | $5.32M | 0.50% | +$3.21M |
| Endeavour Silver Corp.(EXK) | 0 | 100,000 | +100,000 | $0 | $5.31M | 0.50% | +$5.31M |
| Waters Corporation(WAT) | 20,000 | 15,000 | -5,000 | $7.37M | $5.24M | 0.49% | -$2.14M |
| Glaukos Corporation(GKOS) | 0 | 50,000 | +50,000 | $0 | $5.16M | 0.48% | +$5.16M |
| Elanco Animal Health Incorporated(ELAN) | 0 | 350,000 | +350,000 | $0 | $5.00M | 0.47% | +$5.00M |
| The Cooper Companies, Inc.(COO) | 0 | 70,000 | +70,000 | $0 | $4.98M | 0.47% | +$4.98M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 150,000 | 100,000 | -50,000 | $5.10M | $4.86M | 0.45% | -$240.5K |
| Protara Therapeutics, Inc.(TARA) | 1,400,000 | 1,400,000 | 0 | $5.96M | $4.24M | 0.40% | -$1.72M |
| Biohaven Ltd.(BHVN) | 175,000 | 300,000 | +125,000 | $4.21M | $4.23M | 0.40% | +$26.0K |
| Sana Biotechnology, Inc.(SANA) | 2,000,000 | 1,500,000 | -500,000 | $3.36M | $4.09M | 0.38% | +$735.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 100,000 | +100,000 | $0 | $3.64M | 0.34% | +$3.64M |
| Scholar Rock Holding Corporation(SRRK) | 125,000 | 100,000 | -25,000 | $4.02M | $3.54M | 0.33% | -$476.8K |
| Nurix Therapeutics, Inc.(NRIX) | 275,000 | 310,000 | +35,000 | $3.27M | $3.53M | 0.33% | +$263.9K |
| Jasper Therapeutics, Inc.(JSPR) | 575,000 | 590,000 | +15,000 | $2.47M | $3.27M | 0.31% | +$802.0K |
| Catalyst Pharmaceuticals Inc | 150,000 | 150,000 | 0 | $3.64M | $3.25M | 0.30% | -$382.5K |
| Alkermes plcSHS(ALKS) | 150,000 | 100,000 | -50,000 | $4.95M | $2.86M | 0.27% | -$2.09M |
| Terns Pharmaceuticals Inc | 700,000 | 700,000 | 0 | $1.93M | $2.61M | 0.24% | +$679.0K |
| Arcus Biosciences, Inc.(RCUS) | 0 | 300,000 | +300,000 | $0 | $2.44M | 0.23% | +$2.44M |
| Oscar Health, Inc.CL A(OSCR) | 200,000 | 100,000 | -100,000 | $2.62M | $2.14M | 0.20% | -$478.0K |
| Tenax Therapeutics, Inc.(TENX) | 167,000 | 167,000 | 0 | $1.09M | $961.9K | 0.09% | -$131.9K |
| Alto Neuroscience, Inc.(ANRO) | 400,000 | 400,000 | 0 | $864.0K | $880.0K | 0.08% | +$16.0K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 175,000 | 0 | -175,000 | $2.23M | $0 | — | -$2.23M |
| Ascendis Pharma A/SADR(ASND) | 100,000 | 0 | -100,000 | $15.59M | $0 | — | -$15.59M |
| Becton, Dickinson and Company(BDX) | 20,000 | 0 | -20,000 | $4.58M | $0 | — | -$4.58M |
| BioNTech SEADS(BNTX) | 40,000 | 0 | -40,000 | $3.64M | $0 | — | -$3.64M |
| Blueprint Medicines Corp | 145,000 | 0 | -145,000 | $12.83M | $0 | — | -$12.83M |
| BridgeBio Pharma, Inc.(BBIO) | 100,000 | 0 | -100,000 | $3.46M | $0 | — | -$3.46M |
| Bristol-Myers Squibb Company(BMY) | 100,000 | 0 | -100,000 | $6.10M | $0 | — | -$6.10M |
| Cabaletta Bio, Inc.(CABA) | 850,000 | 0 | -850,000 | $1.18M | $0 | — | -$1.18M |
| Crinetics Pharmaceuticals In | 125,000 | 0 | -125,000 | $4.19M | $0 | — | -$4.19M |
| Dyne Therapeutics, Inc.(DYN) | 450,000 | 0 | -450,000 | $4.71M | $0 | — | -$4.71M |
| Fate Therapeutics, Inc.(FATE) | 700,000 | 0 | -700,000 | $553.1K | $0 | — | -$553.1K |
| Gilead Sciences, Inc.(GILD) | 175,000 | 0 | -175,000 | $19.61M | $0 | — | -$19.61M |
| Globus Medical, Inc.CL A(GMED) | 50,000 | 0 | -50,000 | $3.66M | $0 | — | -$3.66M |
| IQVIA Holdings Inc.(IQV) | 30,000 | 0 | -30,000 | $5.29M | $0 | — | -$5.29M |
| Krystal Biotech, Inc.(KRYS) | 60,000 | 0 | -60,000 | $10.82M | $0 | — | -$10.82M |
| Labcorp Holdings Inc.(LH) | 20,000 | 0 | -20,000 | $4.65M | $0 | — | -$4.65M |
| Masimo Corp | 45,000 | 0 | -45,000 | $7.50M | $0 | — | -$7.50M |
| Mereo BioPharma Group plcADS(MREO) | 800,000 | 0 | -800,000 | $1.80M | $0 | — | -$1.80M |
| Palatin Technologies Inc | 1,000,000 | 0 | -1,000,000 | $582.9K | $0 | — | -$582.9K |
| PTC Therapeutics, Inc.(PTCT) | 100,000 | 0 | -100,000 | $5.10M | $0 | — | -$5.10M |
| Repligen Corporation(RGEN) | 20,000 | 0 | -20,000 | $2.54M | $0 | — | -$2.54M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 500,000 | 0 | -500,000 | $7.68M | $0 | — | -$7.68M |
| The Cigna Group(CI) | 10,000 | 0 | -10,000 | $3.29M | $0 | — | -$3.29M |
| Verastem, Inc.(VSTM) | 500,000 | 0 | -500,000 | $3.02M | $0 | — | -$3.02M |